IDEXX Labs (IDXX) Tops Q2 EPS by 30c; Raises Outlook

IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $2.34, $0.30 better than the analyst estimate of $2.04. Revenue for the quarter came in at $826 million versus the consensus estimate of $782.99 million.

GUIDANCE:

IDEXX Labs sees FY2021 EPS of $8.20-$8.36, versus the consensus of $8.10. IDEXX Labs sees FY2021 revenue of $3.17-3.205 billion, versus the consensus of $3.14 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• BofA cuts PG&E to Neutral as California wildfire reforms fall short
• Medtronic jumps on earnings beat and raised guidance